0001652252-16-000106.txt : 20160913 0001652252-16-000106.hdr.sgml : 20160913 20160913180249 ACCESSION NUMBER: 0001652252-16-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160910 FILED AS OF DATE: 20160913 DATE AS OF CHANGE: 20160913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Shannon CENTRAL INDEX KEY: 0001621222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 161883665 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-09-10 0000012208 BIO RAD LABORATORIES INC BIO, BIOB 0001621222 Hall Shannon C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 Executive Vice President Bio-Rad A Common Stock 2016-09-10 4 M 0 240 0 A 667.012 D Bio-Rad A Common Stock 2016-09-11 4 M 0 840 0 A 1507.012 D Bio-Rad A Common Stock 2016-09-12 4 S 0 414 155.0169 D 1093.012 D Restricted Stock Units 0 2016-09-10 4 M 0 240 0 D Bio-Rad A Common Stock 240 720 D Restricted Stock Units 0 2016-09-11 4 M 0 240 0 D Bio-Rad A Common Stock 240 480 D Restricted Stock Units 0 2016-09-11 4 M 0 600 0 D Bio-Rad A Common Stock 600 2400 D Shares of Class A common stock acquired on the vesting of restricted stock units. Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0162 to $155.0174, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest in five equal annual installments beginning September 10, 2015. The restricted stock units vest in five equal annual installments beginning September 11, 2014. The restricted stock units vest in five equal annual installments beginning September 11, 2016. /s/ Ronald W. Hutton, Attorney-in-fact 2016-09-13 EX-24 2 poa.htm


POWER OF ATTORNEY



Know all by these presents, that the undersigned hereby constitutes and appoints each of Ronald

W. Hutton and Christine A. Tsingos, or either of them acting singly, and with full power of

substitution, the undersigned's true and lawful attorney-in-fact to:



(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer

and/or director of Bio-Rad Laboratories, Inc. (the "Company"), Forms 3, 4, 5 and 144 in

accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;



(2) do and perform any and all acts for and on behalf of the undersigned which may be

necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute

any amendment or amendments thereto, and timely file such form with the United States

Securities and Exchange Commission and any stock exchange or similar authority; and



(3) take any other action of any type whatsoever in connection with the foregoing which, in the

opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required

by, the undersigned, it being understood that the documents executed by such attorney-in-fact on

behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall

contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-

fact's discretion.



The undersigned hereby grants to each such attorney-in-fact full power and authority to do and

perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein granted, as fully to all intents and purposes as

the undersigned might or could do if personally present, with full power of substitution or

revocation, hereby ratifying and confirming all that such attorney-in-fact, or such

attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this

power of attorney and the rights and powers herein granted. The undersigned acknowledges

that the foregoing attorneys-in-fact, in serving in such capacity at the request of the

undersigned, are not assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until the undersigned is no longer

required to file Forms 3, 4, 5 and 144 with respect to the undersigned's holdings of and

transactions in securities issued by the Company, unless earlier revoked by the undersigned in a

signed writing delivered to the foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as

of this 1st day September, 2016.



/s/ Shannon Hall